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cited because of space limitations but
were referred to in a review [11] that was
cited. These data reveal important insights
into the mechanisms underlying the hu-
man immune response to Cryptospori-
dium species.
White et al. [1] also point out that
nitazoxanide recently received approval
from the US Food and Drug Adminis-
tration (after the submission of our re-
view) for the treatment of cryptospori-
diosis and giardiasis in children [12].
Brett A. Leav, Melanie Mackay,
and Honorine D. Ward
Division of Geographic Medicine and Infectious
Diseases, Tufts–New England Medical Center,
Boston, Massachusetts
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Persistence of a Methicillin-
Resistant Staphylococcus
aureus Clone in a Drug-
Use Network
Sir—The study by Quagliarello et al. [1]
has shown links between geographic lo-
cation, drug-sharing activities, and the
transmission of staphylococci among
users of injection drugs. Patterns of drug
use, use of inhalation paraphernalia, and
affiliation with 1 of 4 drug-use networks
were identified as major contributors to
the transfer of staphylococci in a nonout-
break setting. The usefulness of a multi-
factorial approach in combining biological
networks, social linkages, and molecular
epidemiological techniques was thereby
demonstrated.
In a previous study, we identified dis-
ability and prior hospitalization in a hos-
pice as risk factors for methicillin-resistant
Staphylococcus aureus (MRSA) carriage
among drug users during the epidemic
spread of a single MRSA clone [2]. Prev-
alence of MRSA colonization among hos-
pice residents was 12.5% in 1998 and
23.3% in 1999. All MRSA isolates had an
identical banding pattern by PFGE. Since
that time, this clone has become endemic
among injection drug users in Zurich. In
order to assess the magnitude of the prob-
lem, in November 2001 we conducted a
follow-up point-prevalence survey of nasal
colonization by MRSA at the same hospice
and drug dispensary in Zurich that we had
studied previously.
We obtained nasal swab samples from
53 patients (22 inpatients and 31 out-
patients) and 18 health care workers at
the hospice. All participants gave verbal
consent to this investigation prior to sam-
pling. Microbiological studies and molec-
ular genotyping were performed as de-
scribed previously [2]. The same standard
questionnaire that we used in our previous
study [2] was used to collect information
on socioeconomic factors, type and fre-
quency of drug use, type of interaction
with other injection drug users, living con-
ditions, and history of hospitalization dur-
ing the preceding 6 months. Additionally,
we determined whether individuals had a
history of MRSA colonization. The use of
antibiotics during the 7 days prior to the
survey and the presence of acute or
chronic skin wounds were assessed as well.
Although the 2 study periods are 2 years
apart, we found no significant difference
in the prevalence rates of MRSA coloni-
zation (table 1). The mean age of the pa-
tients decreased from 36.4 years to 25.4
years. The percentage of men decreased
from 65% in 1999 to 49% in 2001. Table
1 summarizes the results of screening for
colonization with methicillin-susceptible
Staphylococcus aureus (MSSA) and MRSA
for each of the 2 study periods. The pro-
portion of patients colonized with MSSA
decreased markedly. This decrease was sig-
nificant among outpatients ( ). OnPp .01
the other hand, the prevalence of colo-
nization with MSSA and MRSA increased
among the screened health care workers.
Within the 7 days preceding the sam-
pling day in 2001, 22.7% of the patients
had received antibiotics. The use of anti-
biotics was not significantly associated
with colonization by MRSA ( orPp .47)
MSSA ( ) in univariate analysis. NoPp .27
significant relationship was found between
drug consumption in a group setting
and colonization with MRSA ( ) orPp .27
MSSA ( ), although 41.5% of thePp .48
drug users usually consumed drugs in a
group setting. On the other hand, there
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Table 1. Rates of methicillin-resistant Staphylococcus aureus
(MRSA) and methicillin-susceptible S. aureus (MSSA) coloniza-
tion among subjects screened in 1999 and 2001 in a Zurich hospice
frequented by injection drug users.
Subject group
1999
(n p 74)
2001
(n p 71) P
Hospice patients
Total no. screened 50 53 …
With MSSA 22/50 (44) 11/53 (20.7) .08
With MRSA 9/50 (18) 10/53 (18.9) .92
Inpatients
Total no. screened 30 22 …
With MSSA 8/30 (26.6) 5/22 (22.7) 1.0a
With MRSA 7/30 (23.3) 9/22 (40.3) .39
Outpatients
Total no. screened 20 31 …
With MSSA 14/20 (70) 6/31 (19.3) .01
With MRSA 2/20 (10) 1/31 (3.2) .56a
Health care workers
Total no. screened 24 18 …
With MSSA 0/24 (0) 3/18 (16.7) .07a
With MRSA 0/24 (0) 3/18 (16.7) .09
Total no. with MSSA 22/74 (29.7) 14/71 (19.7) .29
Total no. with MRSAb 9/74 (12.2) 13/71 (18.3) .42
NOTE. Data are expressed as no. (%) of subjects screened who had
infection, except as noted.
a Determined using Fishers 2-t.
b The clone of MRSA found in all positive samples obtained in 2001 as was
the same as that found in all positive samples obtained in 1999 [2].
was a significant correlation between prior
hospital stay and colonization with MSSA
( ), but not between prior hospitalPp .03
stay and colonization with MRSA (Pp
). Fresh skin wounds were present in1.0
30.2% of screened patients, and chronic
wounds were present in 13.2%. No sig-
nificant association was found between
the presence of acute or chronic wounds
and colonization with MRSA ( ) orPp .49
MSSA ( ).Pp .17
Our follow-up survey documents stable
endemicity of MRSA colonization among
outpatients and residents of a hospice in
downtown Zurich. This situation may
have implications for other health care in-
stitutions, as the endemic clone might
spread beyond the drug community into
hospitals and other health care institutions
[3]. The detection of MRSA colonization
among health care workers at the hospice
is probably a result of the difficulty of en-
forcing adequate infection control mea-
sures in this particular setting. Our study
expands on the findings of Quagliarello et
al. [1] regarding the importance of the
geographic setting and the influence of so-
cial networks. Much like the crack house
identified by Quagliarello et al. [1] as the
epicenter of the biological networks in
their study, the hospice investigated in our
study plays an important role in trans-
mission and propagation of MRSA colo-
nization. Unlike the crack house, the
hospice is accessible to infection control
interventions. Such interventions were at-
tempted, but without success, as illus-
trated by the persistently high colonization
rate and the discovery of MRSA coloni-
zation among health care workers. Fur-
thermore, our follow-up prevalence sur-
vey, conducted 12 years after the 1999
survey, demonstrates that, once intro-
duced into a network of drug users, a sin-
gle MRSA clone may persist over a pro-
longed time period. We agree with
Quagliarello et al. [2] that there are many
linkages between groups of drug users. To
develop a successful strategy against the
spread of MRSA among drug users and
into other population groups in the com-
munity, it will be important to conduct
additional studies of the dynamics of so-
cial networks among drug users.
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Reply
Sir—We agree with Colombo et al. [1]
that a multifactorial approach that com-
bines biological and social-network meth-
odologies with molecular epidemiology is
